MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2284-2285
Number of pages2
JournalBlood
Volume122
Issue number13
DOIs
Publication statusPublished - Sep 26 2013

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this